Detection of circulating tumor cells in breast cancer patients using multiplex reverse transcription-polymerase chain reaction and specific primers for MGB, PTHRP and KRT19 correlation with clinicopathological features

Anticancer Research

Volumn 34, Issue 11, 2014, Pages 6691-6699

  Skondra, Maria ^a,b   Gkioka, Eliona ^a   Kostakis, Ioannis D ^a   Pissimissis, Nikolaos ^a   Lembessis, Panagiotis ^a   Pectasides, Dimitrios ^b   Koutsilieris, Michael ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Breast cancer; Circulating tumor cells (CTCs); KRT19; MGB; PCR; PTHRP

Indexed keywords

COMPLEMENTARY DNA; CYTOKERATIN 19; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; KI 67 ANTIGEN; MAMMAGLOBIN; PARATHYROID HORMONE RELATED PROTEIN; PROGESTERONE RECEPTOR; MAMMAGLOBIN A; MESSENGER RNA; PARATHYROID HORMONE RECEPTOR 1; RNA; SCGB2A2 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; ARTICLE; BLOOD; BLOOD SAMPLING; BONE METASTASIS; BREAST CANCER; CANCER PATIENT; CANCER STAGING; CELL PROLIFERATION; CIRCULATING TUMOR CELL; DISEASE ASSOCIATION; DISTANT METASTASIS; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MULTIPLEX POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SENSITIVITY AND SPECIFICITY; AGED; BONE TUMOR; BREAST TUMOR; CANCER GRADING; CASE CONTROL STUDY; COMPARATIVE STUDY; FOLLOW UP; GENETICS; LUNG CARCINOMA; LYMPH NODE METASTASIS; MIDDLE AGED; PAGET NIPPLE DISEASE; PATHOLOGY; PROGNOSIS; SECONDARY; TUMOR EMBOLISM;

ADULT; AGED; BONE NEOPLASMS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; KERATIN-19; LYMPHATIC METASTASIS; MAMMAGLOBIN A; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; NEOPLASTIC CELLS, CIRCULATING; PROGNOSIS; RECEPTOR, PARATHYROID HORMONE, TYPE 1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TUMOR MARKERS, BIOLOGICAL;

EID: 84916242987     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. American Cancer Society: Cancer Facts and Figures 2012. Atlada GACS, 2013.
2. Cardoso F, Harbeck N, Fallowfield L, Kyriakides S and Senkus E, on behalf of the ESMO guidelines working group, Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology 23(Suppl 7): vii11-vii19, 2012.
3. Armakolas A, Panteleakou Z, Nezos A, Tsouma A, Skondra M, Lembessis P, Pissimissis N and Koutsilieris M: Detection of the circulating tumor cells in cancer patients. Future Oncol 6(12): 1849-1856, 2010.
4. Jacob K, Sollier C and Jabado N: Circulating tumor cells: detection, molecular profiling and future prospects. Expert Rev Proteomics 4: 741-756, 2007.
5. Pneumaticos SG, Christofides A, Gkioka E, Kalogeropoulos T, Msaouel P and Koutsilieris M: Osteoprotegerin expression during the micro- and macrometastatic phases of the osteoblastic metastasis in prostate cancer: therapeutic implications. Expert Opin Ther Targets 17(12): 1395-1403, 2013.
6. Alix-Panabieres C, Muller V and Pantel K: Current status in human breast cancer micrometastasis. Curr Opin Oncol 19: 558-563, 2007.
7. Smerage JB and Hayes DF: The prognostic implications of circulating tumor cells in patients with breast cancer. Cancer Invest 26(2): 109-114, 2008.
8. Paternili-Brechot P and Benali NL: Circulating tumor cells (CTC) detection: clinical impact and future directions. Cancer Lett 253(2): 180-204, 2007.
9. Katseli A, Maragos H, Nezos A, Syrigos K and Koutsilieris M: Multiplex PCR-Based Detection of Circulating Tumor Cells in Lung Cancer Patients Using KRT19, PTHRP and LUNX Specific Primers. Clinical Lung Cancer 14(5): 513-520, 2013.
10. Panteleakou Z, Lembessis P, Sourla A, Pissimissis N, Polyzos A, Deliveliotis C and Koutsilieris M: Detection of circulating tumor cells in prostate cancer patients: methodological pitfalls and clinical relevance. Mol Med 15(3-4): 101-114, 2009.
11. Katopodis H, Philippou A, Tenta R, Doillon C, Papachroni KK, Papavassiliou AG and Koutsilieris M: MG-63 osteoblast-like cells enhance the osteoprotegerin expression of PC-3 prostate cancer cells. Anticancer Res 29(10): 4013-4018, 2009.
12. Msaouel P, Nandikolla G, Pneumaticos SG and Koutsilieris M: Bone microenvironment-targeted manipulations for the treatment of osteoblastic metastasis in castration-resistant prostate cancer. Expert Opin Investig Drugs 22(11): 1385-1400, 2013.
13. Bartek J, Bartkova J, Taylor-Papadimitriou J, Rejthar A, Kovarik J, Lukas Z and Vojtesek B: Differential expression of keratin 19 in normal human epithelial tissues revealed by monospecific monoclonal antibodies. Histochem J 18: 565-575, 1986.
14. Datta YH, Adams PT, Drobyski WR, Ethier SP, Terry VH and Roth MS: Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. J. Clin. Oncol. 12: 475-482, 1994.
15. Traweek ST, Liu J and Battifora H: Keratin gene expression in non-epithelial tissues. Detection with polymerase chain reaction. Am J Pathol 142: 1111-1118, 1993.
16. Suva LJ, Winslow GA, Wettenhall RE, Hammonds RG, Moseley JM, Diefenbach-Jagger H, Rodda CP, Kemp BE, Rodriguez H and Chen EY: A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression. Science 237: 893-896, 1987.
17. Rankin W, Grill V and Martin TJ: Parathyroid hormone-related protein and hypercalcemia. Cancer 80: 1564-1571, 1997.
18. Southby J, Kissin MW, Danks JA, Hayman JA, Moseley JM, Henderson MA, Bennett RC and Martin TJ: Immunohisto-chemical localization of parathyroid hormone-related protein in human breast cancer. Cancer Res 50: 7710-7716, 1990.
19. Watson MA and Fleming TP: Mammaglobin, a mammary specific member of the uteroglobin gene family, is overexpressed in human breast cancer. Cancer Res 56: 860-865, 1996.
20. Watson MA, Dintzis S, Darrow CM, Voss LE, DiPersio J, Jensen R and Fleming TP: Mammaglobin expression in primary, metastatic, and occult breast cancer. Cancer Res 59: 3028-3031, 1999.
21. Tsouma A, Aggeli C, Lembessis P, Zografos GN, Korkolis DP, Pectasides D, Skondra M, Pissimissis N, Tzonou A and Koutsilieris M.: Multiplex RT-PCR-based detections of CEA, CK20 and EGFR in colorectal cancer patients. World J Gastroenterol 16(47): 5965-5974, 2010.
22. Nezos A, Msaouel P, Pissimissis N, Lembessis P, Sourla A, Armakolas A, Gogas H, Stratigos AJ, Katsambas AD and Koutsilieris M: Methods of detection of circulating melanoma cells: a comparative overview. Cancer Treat Rev 37(4): 284-290, 2011.
23. Thiery JP. Epithelial-mesenchymal transitions in development and pathologies. Curr. Opin. Cell Biol 15(6): 740-746, 2003.
24. Thompson EW, Newgreen DFand Tarin D: Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition? Cancer Res 65: 5991-5995, 2005.
25. Willipinski-Stapelfeldt B, Riethdorf S, Assmann V, Woelfle U, Rau T, Heukeshoven J and Pantel K: Changes in cytoskeletal protein composition indicative of an epithelial-mesenchymal transition in human micrometastatic and primary breast carcinoma cells. Clin. Cancer Res 11: 8006-8014, 2005.
26. Christiansen JJ and Rajasekaran AK: Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastases. Cancer Res 66: 8319-8326, 2006.
27. Coman DR, DeLong PR and MccUtcheon M: Studies on the mechanisms of metastasis; the distribution of tumors in various organs in relation to the distribution of arterial emboli. Cancer Res 11: 648-651, 1951.
28. Mocellin S, Keilholz U, Rossi CR and Nitti D: Circulating tumor cells: the "leukemic phase" of solid cancers. Trends Mol. Med. 12: 130-139, 2006.
29. Peck K, Sher YP, Shih JY, Roffler SR, Wu CW and Yang PC: Detection and quantitation of circulating cancer cells in the peripheral blood of lung cancer patients. Cancer Res 58: 2761-2765, 1998.
30. Yeh KH, Chen YC, Yeh SH, Chen CP, Lin JT and Cheng AL: Detection of circulating cancer cells by nested reverse transcription polymerase chain reaction of cytokeratin-19 (K19)-possible clinical significance in advanced gastric cancer. Anticancer Res 18: 1283-1286, 1998.
31. Aihara T, Noguchi S, Ishikawa O, Furukawa H, Hiratsuka M, Ohigashi H, Nakamori S, Monden M and Imaoka S: Detection of pancreatic and gastric cancer cells in peripheral and portal blood by amplification of keratin 19 mRNA with reverse transcriptase-polymerase chain reaction. Int J Cancer 72: 408-411, 1997.
32. Hoffmann K, Kerner C, Wilfert W, Mueller M, Thiery J, Hauss J and Witzigmann H: Detection of disseminated pancreatic cells by amplification of cytokeratin-19 with quantitative RT-PCR in blood, bone marrow and peritoneal lavage of pancreatic carcinoma patients. World J Gastroenterol 13: 257-263, 2007.
33. Stathopoulou A, Gizi A, Perraki M, Apostolaki S, Malamos N, Mavroudis D, Georgoulias V and Lianidou ES: Real-time quantification of CK-19 mRNA-positive cells in peripheral blood of breast cancer patients using the lightcycler system. Clin Cancer Res 9: 5145-5151, 2003.
34. Balducci E, Azzarello G, Valori L, Toffolatti L, Bolgan L, Valenti MT, Bari M, Pappagallo GL, Ausoni S and Vinante O: A new nested primer pair improves the specificity of CK-19 mRNA detection by RT-PCR in occult breast cancer cells. Int J Biol Markers 20: 28-33, 2005.
35. Zieglschmid V, Hollmann C and Bocher O: Detection of disseminated tumor cells in peripheral blood. Crit Rev Clin Lab Sci 42: 155-196, 2005.
36. Abou-Samra AB, Juppner H, Force T, Freeman MW, Kong XF, Schipani E, Urena P, Richards J, Bonventre JV and Potts JT: Expression cloning of a common receptor for parathyroid hormone and parathyroid hormone-related peptide from rat osteoblast-like cells: a single receptor stimulates intracellular accumulation of both cAMP and inositol trisphosphates and increases intracellular intracellular free calcium. Proc Natl Acad Sci USA 89: 2732-2736, 1992.
37. Juppner H and Hesch RD: Biochemical characterization of cellular hormone receptors. Curr Top Pathol 83: 53-69, 1991.
38. Strewler GJ, Stern PH, Jacobs JW, Eveloff J, Klein RF, Leung SC, Rosenblatt M and Nissenson RA: Parathyroid hormonelike protein from human renal carcinoma cells. Structural and functional homology with parathyroid hormone. J Clin Invest 80: 1803-1807, 1987.
39. De Papp AE and Stewart AF: Parathyroid hormone-related protein a peptide of diverse physiologic functions. Trends Endocrinol. Metab 4: 181-187, 1993.
40. Rodda CP, Kubota M, Heath JA, Ebeling PR, Moseley JM, Care AD, Caple IW and Martin TJ: Evidence for a novel parathyroid hormone-related protein in fetal lamb parathyroid glands and sheep placenta: comparisons with a similar protein implicated in humoral hypercalcemia of malignancy. J Endocrinol 117: 261-271, 1988.
41. Thomas RJ, Guise TA, Yin JJ, Elliott J, Horwood NJ, Martin TJ and Gillespie MT: Breast cancer cells interact with osteoblasts to support osteoclast formation. Endocrinology 140: 4451-4458, 1999.
42. Guise TA: Parathyroid hormone-related protein and bone metastases. Cancer 80: 1572-1580, 1997.
43. Leygue E, Snell L, Dotzlaw H, Hole K, Troup S, Hiller-Hitchcock T, Murphy LC and Watson PH: Mammaglobin, a potential marker of breast cancer nodal metastasis. J Pathol 189: 28-33, 1999.
44. Klug J, Beier HM, Bernard A, Chilton BS, Fleming TP, Lehrer RI, Miele L, Pattabiraman N and Singh G:Uteroglobin/Clara cell 10-kDa family of proteins: nomenclature committee report. Ann NYAcad Sci 923: 348-354, 2000.
45. Min CJ, Tafra L and Verbanac KM:. Identification of superior markers for polymerase chain reaction detection of breast cancer metastases in sentinel lymph nodes. Cancer Res 58: 4581-4584, 1998.
46. Nakagawa T and Martinez SR: Detection of Circulating Tumor Cells in Early-Stage Breast Cancer Metastasis to Axillary Lymph Nodes. Clin Cancer Res 13: 4105-4110, 2007.